[1] Yoshida H, Mamada Y, Taniai N, et al. Spontaneous ruptured hepatocellular carcinoma[J]. Hepatol Res, 2016,46(1):115-132.
[2] 卢绍伟,卢 倩,彭永华,等.肝癌破裂出血的快速诊断及急救处理[J].临床急诊杂志,2017,18(12):961-963.
[3] 朱 宇,刘子君,杨士勇.25例肝癌破裂出血患者的诊断与治疗[J].江苏医药,2019,45(3):277-279
[4] 方水龙. 肝癌介入治疗用于原发性肝癌手术切除术后复发的影响因素分析[J]. 临床研究,2018,26(12):58-59.
[5] 韦 勇,涂 蓉,邓丹琼,等. 原发性肝癌介入治疗的临床疗效评价[J].现代肿瘤医学,2011,19(12):2500-2502.
[6] Jiang F Q,Wei L, Chao Y.Curative effect of transcatheter arterial chemoembolization combined with radiofrequency ablation in treating hepatic cell carcinoma and the effect on serrum markers[J].Cancer Biomark,2016,22(8):86-90.
[7] Matsumoto T, Chung H, Suginoshita Y, et al. Outcomes and prognostic factors in patients with spontaneously ruptured hepatocellular carcinoma[J]. Hepatogastroenterology,2015,62(140):942-946.
[8] 王凝芳.急诊TACE介入治疗肝癌破裂出血的效果及安全性研究 [J].中国现代药物应用,2018,12(7):27-29.
[9] 王宏博,廖晓峰,孙华朋,等.门静脉高压症合并原发性肝癌破裂出血的治疗(附120例报告)[J].腹部外科,2016,29(5):375-379.
[10] Kubo S, Takemura S, Tanaka S, et al. Management of hepatitis B virusinfection during treatment for hepatitis B virus-related hepatocellularcarcinoma[J].Word J Gastroenterol,2015,21(27):8249-8255
[11] 程亚茹.102例原发性肝癌患者的TACE治疗及预后影响因素分析[D]. 济南:山东大学,2016.
[12] 张 黎.中晚期原发性肝癌介入治疗的临床效果及对肝功能的影响.[J].医学信息,2018,31(9):20-22.
[13] 王 杰,涂 兵.原发性肝癌破裂出血治疗研究进展[J].现代医药卫生,2019,35(14):2173-2175.
[14] 陈敏山,王小辉.TACE在伴门静脉癌栓肝癌治疗中的应用[J].中国普外基础与临床杂志,2019,26(5):524-527.
[15] 王 刚,乔祖俊,乔超峰.经导管肝动脉化疗栓塞术治疗原发性肝癌自发性破裂出血的体会[J].河南外科学杂志,2018,24(3):100-101.